Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daivobet gel versus betamethasone, calcipotriol, and vehicle in psoriasis vulgaris
2005-003215-78Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- Sep 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of calcipotriol + betamethasone, betamethasone dipropionate and calcipotriol in plaque psoriasis (4 arms), sponsored by LEO Pharma. Primary endpoint: Controlled disease at week 8. Started Sep 2005; status: completed.
02
Drugs
calcipotriol + betamethasonebetamethasone dipropionatecalcipotriol
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2005-003215-78.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003215-78.